(PCVX) Vaxcyte - Performance -47.7% in 12m
Compare PCVX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
39.76%
#18 in Group
Rel. Strength
11.65%
#6783 in Universe
Total Return 12m
-47.71%
#98 in Group
Total Return 5y
28.83%
#38 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -6.55%
(unknown) Percentile in Group
12m Total Return: PCVX (-47.7%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: PCVX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PCVX
Total Return (including Dividends) | PCVX | XBI | S&P 500 |
---|---|---|---|
1 Month | -53.27% | -5.85% | -3.01% |
3 Months | -59.56% | -11.95% | -3.15% |
12 Months | -47.71% | -11.00% | 10.19% |
5 Years | 28.83% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | PCVX | XBI | S&P 500 |
1 Month | -48.7% | -59.8% | -5.5% |
3 Months | -77.9% | -70.5% | -58.4% |
12 Months | 38.6% | -6.9% | 84.1% |
5 Years | 76.8% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #200 | -50.4% | -51.8% |
3 Month | #183 | -54.1% | -58.2% |
12 Month | #98 | -41.3% | -52.6% |
5 Years | #29 | 59.6% | -35.5% |
FAQs
Does PCVX Vaxcyte outperforms the market?
No,
over the last 12 months PCVX made -47.71%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months PCVX made -59.56%, while XBI made -11.95%.
Over the last 3 months PCVX made -59.56%, while XBI made -11.95%.
Performance Comparison PCVX vs Indeces and Sectors
PCVX vs. Indices PCVX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -50.1% | -50.3% | -70.4% | -57.9% |
US NASDAQ 100 | QQQ | -49.2% | -49.2% | -69.6% | -56.3% |
US Dow Jones Industrial 30 | DIA | -50.3% | -51.1% | -71.3% | -57.2% |
German DAX 40 | DAX | -48.8% | -49.9% | -87.2% | -69.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | -49.9% | -53.5% | -55.2% | -56.8% |
Hongkong Hang Seng | HSI | -52.1% | -56.0% | -61.2% | -65.0% |
India NIFTY 50 | INDA | -51.2% | -61.1% | -60.0% | -48.4% |
Brasil Bovespa | EWZ | -50.3% | -61.6% | -62.4% | -36.0% |
PCVX vs. Sectors PCVX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -48.6% | -49.5% | -78.5% | -66.9% |
Consumer Discretionary | XLY | -50.9% | -49.4% | -73.7% | -61.8% |
Consumer Staples | XLP | -52.9% | -51.4% | -71.2% | -58.7% |
Energy | XLE | -51.2% | -61.3% | -76.0% | -48.5% |
Financial | XLF | -50.6% | -50.6% | -82.5% | -70.0% |
Health Care | XLV | -50.6% | -50.1% | -65.7% | -49.4% |
Industrial | XLI | -50.5% | -52.6% | -69.7% | -56.2% |
Materials | XLB | -51.2% | -53.8% | -62.3% | -43.8% |
Real Estate | XLRE | -52.2% | -50.6% | -67.3% | -61.1% |
Technology | XLK | -49.0% | -49.3% | -65.3% | -49.7% |
Utilities | XLU | -53.4% | -54.1% | -69.5% | -72.9% |
Aerospace & Defense | XAR | -49.5% | -54.6% | -74.3% | -68.6% |
Biotech | XBI | -45.6% | -47.4% | -52.7% | -36.7% |
Homebuilder | XHB | -50.6% | -53.4% | -51.0% | -40.0% |
Retail | XRT | -52.4% | -52.8% | -66.3% | -42.9% |